Tumor Markers--Strategic Assessments of Major Suppliers and Emerging Market Entrants

July 2016 | 80 pages | ID: T79390B9702EN
Venture Planning Group

Abstracts

This new 80-page report from VPGMarketResearch.com provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. The assessments include: ul>li>Sales/li>li>Product portfolios/li>li>Distribution tactics/li>li>Technological know-how/li>li>New products in R&D/li>li>Collaborative arrangements/li>li>Business strategies./li>/ul>Contains 80 pages

Contents

Abbott
AdnaGen/Alere
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio Rad
CellSearch
Cepheid
Correlogic Systems/Vermillion
Decode Genetics
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Elitech Group
Epigenomics
Enterix
EnzBiochem
Exact Sciences
Fujirebio
Guided Therapeutics
Hologic/GenProbe
Kreatech/Leica
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
OncoLab
Ortho Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen
Quest Diagnostics
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
ThermFisher
Tosoh
Veridex
WakPure Chemicals
Wallac/PE
Zila